Last Updated: August 2, 2026

NICARDIPINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Nicardipine Hydrochloride, and when can generic versions of Nicardipine Hydrochloride launch?

Nicardipine Hydrochloride is a drug marketed by Amneal, Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Navinta Llc, Pharmobedient, Senores Pharms, Am Regent, Chengdu Shuode, Eugia Pharma, Hikma, Hikma Intl Pharms, Mankind Pharma, Micro Labs, Nanjing King Friend, Qilu Pharm Hainan, Somerset Theraps Llc, Sun Pharm, Inforlife, Caplin, and Cipla. and is included in twenty-six NDAs.

The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Nicardipine Hydrochloride

A generic version of NICARDIPINE HYDROCHLORIDE was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for NICARDIPINE HYDROCHLORIDE?
  • What are the global sales for NICARDIPINE HYDROCHLORIDE?
  • What is Average Wholesale Price for NICARDIPINE HYDROCHLORIDE?
Summary for NICARDIPINE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for NICARDIPINE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER Injection nicardipine hydrochloride 2.5 mg/mL, 10 mL Ampoules 019734 1 2006-12-27

US Patents and Regulatory Information for NICARDIPINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Intl Pharms NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE nicardipine hydrochloride INJECTABLE;INTRAVENOUS 022276-003 Apr 7, 2016 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Somerset Theraps Llc NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 090664-001 Nov 17, 2009 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Micro Labs NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 216420-001 Jul 7, 2023 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 078405-001 Nov 17, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Nanjing King Friend NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 216819-001 Aug 20, 2025 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Amneal NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 218202-001 Apr 10, 2024 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pharmobedient NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 074642-002 Jul 18, 1996 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.